The frequencies of lymphocyte subsets on ?day 30?correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation

被引:2
作者
Yao, Yanhua [1 ]
Li, Bohan [1 ]
Li, Jie [1 ]
Yao, Di [1 ]
Ling, Jing [1 ]
Hu, Yixin [1 ]
Fan, Liyan [1 ]
Wan, Lin [1 ]
Kong, Lingjun [1 ]
Xiao, Peifang [1 ]
Lu, Jun [1 ]
Meng, Lijun [1 ]
Li, Zhiheng [1 ]
Hu, Shaoyan [1 ,2 ]
Tian, Yuanyuan [1 ,2 ]
机构
[1] Soochow Univ, Childrens Hosp, Dept Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Childrens Hosp, Dept Hematol Oncol, Zhongnan St 92, Suzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Pediatric; Allogeneic hematopoietic stem cell; transplantation; Lymphocyte subsets; Graft versus host disease; VERSUS-HOST-DISEASE; IMMUNE RECONSTITUTION; ALLOGENEIC TRANSPLANTATION; B-CELLS; GRAFT; BLOOD; PREDICTS; RECOVERY; SURVIVAL; MARROW;
D O I
10.1016/j.imlet.2023.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We aimed to determine the relationship between lymphocyte subsets on day 30 (D30) and prognosis after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. We retrospectively examined the clinical outcomes and lymphocyte subsets on D30 after allo-HSCT in 115 pediatric patients at the Children's Hospital of Soochow University between January 2016 and June 2019. Measurements were performed using flow cytometry on D30. Lymphocyte subsets were compared among the umbilical cord blood (UCB) (n = 22), HLA-matched sibling donor (MSD) (n = 14), haploidentical donor transplantation (HID) (n = 57), and unrelated donor transplantation (UD) (n = 22) groups. The relationships between the frequencies and counts of lymphocyte subsets and clinical outcomes were analyzed. T and B cell counts were the highest in the MSD group compared to the other groups, and natural killer cell counts were the highest in the UCB group. Lymphocyte subsets on D30 after allo-HSCT were correlated with the occurrence of acute (aGVHD) and chronic graft versus host disease (cGVHD). A high frequency of B cells (>= 4.65%) was associated with the development of severe aGVHD. High frequencies of CD4+T (>= 10.25%) were correlated with extensive cGVHD. Moreover, a high frequency of CD4+T cells (>= 9.80%) was correlated with GVHD-free and failure-free survival (GFFS) after allo-HSCT. However, on D30, there were no statistically significant correlations between viral infections and lymphocyte subsets. The frequencies of lymphocyte subsets on D30 after allo-HSCT are good indicators of prognosis after allo-HSCT in children.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 40 条
[1]   Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications [J].
Annaloro, Claudio ;
Serpenti, Fabio ;
Saporiti, Giorgia ;
Galassi, Giulia ;
Cavaliero, Francesca ;
Grifoni, Federica ;
Goldaniga, Maria ;
Baldini, Luca ;
Onida, Francesco .
FRONTIERS IN IMMUNOLOGY, 2021, 11
[2]   Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in Children [J].
Bartelink, Imke Heleen ;
Belitser, Svetlana V. ;
Knibbe, Catherijne A. J. ;
Danhof, Meindert ;
de Pagter, Anne J. ;
Egberts, Toine C. G. ;
Boelens, Jaap Jan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) :305-313
[3]   Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD [J].
Bejanyan, Nelli ;
Brunstein, Claudio G. ;
Cao, Qing ;
Lazaryan, Aleksandr ;
Luo, Xianghua ;
Curtsinger, Julie ;
Mehta, Rohtesh S. ;
Warlick, Erica ;
Cooley, Sarah A. ;
Blazar, Bruce R. ;
Miller, Jeffrey S. ;
Weisdorf, Daniel ;
Wagner, John E. ;
Verneris, Michael R. .
BLOOD ADVANCES, 2018, 2 (08) :909-922
[4]   Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome [J].
Chang, Ying-Jun ;
Zhao, Xiang-Yu ;
Xu, Lan-Ping ;
Liu, Dai-Hong ;
Liu, Kai-Yan ;
Chen, Yu-Hong ;
Wang, Yu ;
Zhang, Xiao-Hui ;
Zhao, Xiao-Su ;
Han, Wei ;
Chen, Huan ;
Wang, Feng-Rong ;
Lv, Meng ;
Huang, Xiao-Jun .
LEUKEMIA & LYMPHOMA, 2013, 54 (12) :2671-2677
[5]   Current and emerging strategies for the prevention of graft-versus-host disease [J].
Choi, Sung Won ;
Reddy, Pavan .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) :536-547
[6]   Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation [J].
Cwynarski, K ;
Ainsworth, J ;
Cobbold, M ;
Wagner, S ;
Mahendra, P ;
Apperley, J ;
Goldman, J ;
Craddock, C ;
Moss, PAH .
BLOOD, 2001, 97 (05) :1232-1240
[7]   Improving engraftment and immune reconstitution in umbilical corc blooc transplantation [J].
Danby, Robert ;
Rocha, Vanderson .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[8]   Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture [J].
de Lima, Marcos ;
McNiece, Ian ;
Robinson, Simon N. ;
Munsell, Mark ;
Eapen, Mary ;
Horowitz, Mary ;
Alousi, Amin ;
Saliba, Rima ;
McMannis, John D. ;
Kaur, Indreshpal ;
Kebriaei, Partow ;
Parmar, Simrit ;
Popat, Uday ;
Hosing, Chitra ;
Champlin, Richard ;
Bollard, Catherine ;
Molldrem, Jeffrey J. ;
Jones, Roy B. ;
Nieto, Yago ;
Andersson, Borje S. ;
Shah, Nina ;
Oran, Betul ;
Cooper, Laurence J. N. ;
Worth, Laura ;
Qazilbash, Muzaffar H. ;
Korbling, Martin ;
Rondon, Gabriela ;
Ciurea, Stefan ;
Bosque, Doyle ;
Maewal, Ila ;
Simmons, Paul J. ;
Shpall, Elizabeth J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (24) :2305-2315
[9]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[10]   CD19+CD21low B Cells and CD4+CD45RA+CD31+ T Cells Correlate with First Diagnosis of Chronic Graft-versus-Host Disease [J].
Greinix, Hildegard T. ;
Kuzmina, Zoya ;
Weigl, Roman ;
Koermoczi, Ulrike ;
Rottal, Arno ;
Wolff, Daniel ;
Kralj, Mateja ;
Kalhs, Peter ;
Mitterbauer, Margit ;
Rabitsch, Werner ;
Edinger, Matthias ;
Holler, Ernst ;
Pickl, Winfried F. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) :250-258